KLTO (Klotho Neurosciences Inc) Prakiraan pendapatan perusahaan
Optimizing biocomponent supplies through a laboratory network supports margins, confirming Klotho Neurosciences Inc (KLTO) sales volume forecasts. Meanwhile, 0.00 indicates the current level. The absence of capital expenditures is ensured by outsourcing production and testing. Stable demand for neuropreparations makes the asset defensive, isolating it from global economic downturns.
Rincian metrik keuangan lan pasar anewmeds.com (KLTO)
- rega saiki lan proyeksi nilai saham:
- indikator valuasi pasar bisnis:
- data ekuitas miturut neraca:
- rincian struktur utang lan likuiditas bisnis:
Utang marang Ekuitas Klotho Neurosciences Inc|KLTO - Koefisien utang jangka dawa marang modal|Utang jangka cendhak marang ekuitas Klotho Neurosciences Inc|KLTO - Utang kumulatif perusahaan|Rasio utang marang kapitalisasi buku Klotho Neurosciences Inc|KLTO - Gunggunge utang jangka dawa|Utang jangka cendhak perusahaan Klotho Neurosciences|Rasio cepet anewmeds.com
- statistik bathi lan rasio pasar:
KLTO - Asil keuangan resik|Proyeksi bathi mangsa ngarep Klotho Neurosciences Inc|KLTO - Kapitalisasi marang bathi|Rega marang bathi mangsa ngarep ANEW Medical, Inc.|KLTO - Rasio P/E diaturake wutah|Pangali EV/EBITDA Klotho Neurosciences|KLTO - Bathi operasional sadurunge ngurangi amortisasi|Bathi resik saben saham (EPS TTM) Klotho Neurosciences|KLTO - Bathi resik saben siji saham sajrone rolas wulan pungkasan|Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan anewmeds.com|KLTO - Prakiraan wutah bathi resik saben saham ing taun iki|Prakiraan wutah bathi saben saham kanggo taun ngarep Klotho Neurosciences Inc
- data dodolan lan asil:
Analisis kabeh metrik perusahaan:KLTO anewmeds.com
The success of Klotho Neurosciences Inc (KLTO) depends on the startup's ability to secure grants through academic partnerships. This indicator assesses market expectations for future cash flows, leading final reports. By analyzing the company's prospective sales dynamics, an investor sees a real-time assessment of management efficiency during the preclinical phase. The metric transforms market quotes into a revenue forecast; however, a high valuation does not guarantee the absence of asset volatility.
Pesaing utama
Volume dodolan mangsa ngarep perusahaan BIIB (Biogen)|NBIX (Neurocrine Biosciences, Inc.) - Pendapatan mangsa ngarep perusahaan|Prakiraan pendapatan perusahaan Regencell RGC|Prakiraan volume pendapatan perusahaan AXSM (Axsome Therapeutics Inc)|ACADIA Pharmaceuticals - Prakiraan volume dodolan|XENE - Prakiraan volume dodolan|VKTX: Prakiraan volume dodolan|Pendapatan sing dikarepake perusahaan SUPN (Supernus)|CPRX (Catalyst Pharmaceuticals Inc) - Prakiraan volume dodolan|DNLI: Pendapatan mangsa ngarep perusahaan|Prakiraan pendapatan perusahaan harmonybiosciences.com (HRMY)|Biohaven - Prakiraan pendapatan perusahaan|Prakiraan volume dodolan AMLX (amylyx.com)|Trevi Pharma (TRVI) - Volume dodolan sing dikarepake perusahaan|Praxis Corp - Prakiraan volume dodolan|Anavex Corp (AVXL) - Volume dodolan mangsa ngarep perusahaan|CBLL: Prakiraan volume dodolan|Prothena Biosciences - Pendapatan mangsa ngarep perusahaan|ALEC (alector.com) - Prakiraan volume dodolan|Prakiraan pendapatan perusahaan ANNX (Annexon Biosciences)|Prakiraan pendapatan perusahaan Omeros Corporation (OMER)|Neurogene Corp - Prakiraan pendapatan perusahaan|Prakiraan pendapatan perusahaan AC Immune S.A. ACIU|Dodolan mangsa ngarep perusahaan Voyager Therapeutics (VYGR)|Neumora - Prakiraan volume dodolan|Pendapatan sing dikarepake perusahaan SCLX|Tevogen Bio Inc. (TVGN) - Prakiraan pendapatan perusahaan|Prakiraan pendapatan perusahaan ACOG|CGTX (cogrx.com) - Prakiraan volume dodolan|Volume dodolan mangsa ngarep perusahaan inhibikase.com (IKT)|Prakiraan pendapatan perusahaan Cassava Sciences Inc (SAVA)|Dodolan mangsa ngarep perusahaan Assertio|Prakiraan volume dodolan COYA (Coya Therapeutics, Inc.)|Prakiraan volume pendapatan perusahaan VTGN (VistaGen Therapeutics Inc)|OVID: Volume dodolan mangsa ngarep perusahaan|ABOS: Prakiraan pendapatan perusahaan|CervoMed (CRVO) - Prakiraan pendapatan perusahaan|Volume dodolan sing dikarepake perusahaan Alterity Therapeutics Ltd (ATHE)|CLNN (Clene) - Prakiraan volume dodolan|Prakiraan pendapatan perusahaan PEPG (PepGen)|Volume dodolan mangsa ngarep perusahaan JUNS (Jupiter Neurosciences, Inc.)|Prakiraan volume dodolan relmada.com (RLMD)|Prakiraan pendapatan perusahaan Annovis Bio Corp ANVS|GRCE: Prakiraan pendapatan perusahaan|AIFF - Prakiraan pendapatan perusahaan|Volume dodolan sing dikarepake perusahaan NeuroSense Therapeutics Ltd|Reviva Pharmaceuticals (RVPH) - Prakiraan pendapatan perusahaan|Prakiraan pendapatan perusahaan MTVA|Volume dodolan mangsa ngarep perusahaan NRXS|Volume dodolan mangsa ngarep perusahaan Helius Medical (HSDT)|Prakiraan volume dodolan PASG|Neuphoria Therapeutics - Prakiraan pendapatan perusahaan|Prakiraan pendapatan perusahaan Minerva Neurosciences, Inc. NERV|Prakiraan volume dodolan Athira Pharma ATHA|ADXN: Volume dodolan mangsa ngarep perusahaan|Volume dodolan sing dikarepake perusahaan Alzamend Neuro|Cyclerion Therapeutics Inc. (CYCN) - Prakiraan pendapatan perusahaan|Volume dodolan sing dikarepake perusahaan Protagenic Therapeutics (PTIX)|KTTA (pasitheaclinics.com) - Prakiraan volume dodolan|Volume dodolan mangsa ngarep perusahaan Cortigent (CRGT)|Prakiraan volume dodolan ATXI|BCLI - Volume dodolan sing dikarepake perusahaan|Prakiraan volume dodolan CARA (Cara Therapeutics, Inc)|Chromocell Therapeutics Corporation (CHRO) - Volume dodolan sing dikarepake perusahaan|ELYM - Prakiraan pendapatan perusahaan|Prakiraan dodolan perusahaan intracellulartherapies.com (ITCI)|Longboard (LBPH) - Prakiraan pendapatan perusahaan|Marinus Pharmaceuticals Inc - Pendapatan mangsa ngarep perusahaan|Volume dodolan mangsa ngarep perusahaan NKGN|NeuroBo - Pendapatan sing dikarepake perusahaan|Prakiraan pendapatan perusahaan Sage Therapeutics, Inc (SAGE)|Volume dodolan mangsa ngarep perusahaan Synaptogenix SNPX|Trevena, Inc. - Volume dodolan mangsa ngarep perusahaan|VIGL: Prakiraan pendapatan perusahaan|WENA: Volume dodolan mangsa ngarep perusahaan|Volume dodolan sing dikarepake perusahaan Cerevel Therapeutics
